nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—ADK—Purine salvage—APRT—nephrolithiasis	0.0973	0.178	CbGpPWpGaD
Adenosine—ADA—Purine salvage—APRT—nephrolithiasis	0.0662	0.121	CbGpPWpGaD
Adenosine—ADK—Purine metabolism—APRT—nephrolithiasis	0.0462	0.0847	CbGpPWpGaD
Adenosine—Atrioventricular block second degree—Hydrochlorothiazide—nephrolithiasis	0.0385	0.11	CcSEcCtD
Adenosine—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.0315	0.0901	CcSEcCtD
Adenosine—ADA—Purine metabolism—APRT—nephrolithiasis	0.0314	0.0575	CbGpPWpGaD
Adenosine—ADK—Nucleotide metabolism—APRT—nephrolithiasis	0.0232	0.0425	CbGpPWpGaD
Adenosine—Adenosine monophosphate—APRT—nephrolithiasis	0.0206	1	CrCbGaD
Adenosine—ADA—Nucleotide metabolism—APRT—nephrolithiasis	0.0158	0.0289	CbGpPWpGaD
Adenosine—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0425	CcSEcCtD
Adenosine—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0411	CcSEcCtD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0137	0.0252	CbGpPWpGaD
Adenosine—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0133	0.038	CcSEcCtD
Adenosine—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0363	CcSEcCtD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0126	0.023	CbGpPWpGaD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0126	0.023	CbGpPWpGaD
Adenosine—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.011	0.0315	CcSEcCtD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00953	0.0175	CbGpPWpGaD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00953	0.0175	CbGpPWpGaD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00886	0.0162	CbGpPWpGaD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00886	0.0162	CbGpPWpGaD
Adenosine—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00876	0.0251	CcSEcCtD
Adenosine—ADA—renal system—nephrolithiasis	0.00868	0.103	CbGeAlD
Adenosine—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00842	0.0241	CcSEcCtD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0079	0.0145	CbGpPWpGaD
Adenosine—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00785	0.0225	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00784	0.0144	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00784	0.0144	CbGpPWpGaD
Adenosine—ADK—nephron tubule—nephrolithiasis	0.0078	0.0923	CbGeAlD
Adenosine—DPP4—nephron tubule—nephrolithiasis	0.00756	0.0895	CbGeAlD
Adenosine—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00756	0.0216	CcSEcCtD
Adenosine—ADK—renal system—nephrolithiasis	0.00709	0.0839	CbGeAlD
Adenosine—SLC28A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00699	0.0128	CbGpPWpGaD
Adenosine—DPP4—renal system—nephrolithiasis	0.00687	0.0814	CbGeAlD
Adenosine—ADK—kidney—nephrolithiasis	0.00685	0.0811	CbGeAlD
Adenosine—ADORA1—renal system—nephrolithiasis	0.00682	0.0807	CbGeAlD
Adenosine—ADK—cortex of kidney—nephrolithiasis	0.00667	0.079	CbGeAlD
Adenosine—DPP4—kidney—nephrolithiasis	0.00664	0.0787	CbGeAlD
Adenosine—ADORA1—kidney—nephrolithiasis	0.00659	0.078	CbGeAlD
Adenosine—DPP4—cortex of kidney—nephrolithiasis	0.00647	0.0766	CbGeAlD
Adenosine—ADORA1—cortex of kidney—nephrolithiasis	0.00642	0.076	CbGeAlD
Adenosine—ADORA1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00641	0.0117	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00639	0.0117	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00639	0.0117	CbGpPWpGaD
Adenosine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00637	0.0182	CcSEcCtD
Adenosine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00606	0.0174	CcSEcCtD
Adenosine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00603	0.0173	CcSEcCtD
Adenosine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0059	0.0169	CcSEcCtD
Adenosine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00562	0.0161	CcSEcCtD
Adenosine—ADORA2B—G alpha (s) signalling events—PTH—nephrolithiasis	0.00562	0.0103	CbGpPWpGaD
Adenosine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00549	0.0157	CcSEcCtD
Adenosine—ADORA2A—GPCRs, Other—CHRM3—nephrolithiasis	0.00516	0.00946	CbGpPWpGaD
Adenosine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00515	0.0147	CcSEcCtD
Adenosine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00512	0.0147	CcSEcCtD
Adenosine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00493	0.0141	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00484	0.00887	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00484	0.00887	CbGpPWpGaD
Adenosine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00472	0.0135	CcSEcCtD
Adenosine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00471	0.0135	CcSEcCtD
Adenosine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00467	0.0134	CcSEcCtD
Adenosine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00465	0.0133	CcSEcCtD
Adenosine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00453	0.013	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0045	0.00825	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0045	0.00825	CbGpPWpGaD
Adenosine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0045	0.0129	CcSEcCtD
Adenosine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00442	0.0126	CcSEcCtD
Adenosine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00439	0.0126	CcSEcCtD
Adenosine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00431	0.0123	CcSEcCtD
Adenosine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00425	0.0122	CcSEcCtD
Adenosine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00422	0.0121	CcSEcCtD
Adenosine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00419	0.012	CcSEcCtD
Adenosine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00409	0.0117	CcSEcCtD
Adenosine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00408	0.0117	CcSEcCtD
Adenosine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00404	0.0116	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00401	0.00735	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00401	0.00735	CbGpPWpGaD
Adenosine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.004	0.0115	CcSEcCtD
Adenosine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00392	0.0112	CcSEcCtD
Adenosine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00386	0.011	CcSEcCtD
Adenosine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00383	0.011	CcSEcCtD
Adenosine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00379	0.0109	CcSEcCtD
Adenosine—ADORA2A—G alpha (s) signalling events—PTH—nephrolithiasis	0.00369	0.00676	CbGpPWpGaD
Adenosine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00366	0.0105	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00357	0.0102	CcSEcCtD
Adenosine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00352	0.0101	CcSEcCtD
Adenosine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0035	0.01	CcSEcCtD
Adenosine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00349	0.00998	CcSEcCtD
Adenosine—ADORA2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00342	0.00626	CbGpPWpGaD
Adenosine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00335	0.0096	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00321	0.00588	CbGpPWpGaD
Adenosine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00892	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00293	0.00536	CbGpPWpGaD
Adenosine—ADORA1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0029	0.00532	CbGpPWpGaD
Adenosine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00289	0.00827	CcSEcCtD
Adenosine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00281	0.00806	CcSEcCtD
Adenosine—ADK—Metabolism—GRHPR—nephrolithiasis	0.00278	0.0051	CbGpPWpGaD
Adenosine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00743	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00258	0.00473	CbGpPWpGaD
Adenosine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00714	CcSEcCtD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00249	0.00456	CbGpPWpGaD
Adenosine—ADK—Metabolism—AGXT—nephrolithiasis	0.00248	0.00454	CbGpPWpGaD
Adenosine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00708	CcSEcCtD
Adenosine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00707	CcSEcCtD
Adenosine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00703	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—RGS14—nephrolithiasis	0.00234	0.00429	CbGpPWpGaD
Adenosine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00667	CcSEcCtD
Adenosine—ADORA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00224	0.00411	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00223	0.00408	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00219	0.00402	CbGpPWpGaD
Adenosine—ADK—Metabolism—APRT—nephrolithiasis	0.00211	0.00386	CbGpPWpGaD
Adenosine—ADK—Metabolism—SLC26A1—nephrolithiasis	0.00211	0.00386	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—PTH—nephrolithiasis	0.00204	0.00374	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—RGS14—nephrolithiasis	0.00199	0.00365	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00192	0.00352	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CHRM3—nephrolithiasis	0.0019	0.00347	CbGpPWpGaD
Adenosine—ADA—Metabolism—GRHPR—nephrolithiasis	0.00189	0.00347	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.00174	0.00319	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—PTH—nephrolithiasis	0.00173	0.00318	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00169	0.0031	CbGpPWpGaD
Adenosine—ADA—Metabolism—AGXT—nephrolithiasis	0.00169	0.00309	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ADCY10—nephrolithiasis	0.00163	0.00298	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—DGKH—nephrolithiasis	0.00158	0.0029	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00154	0.00282	CbGpPWpGaD
Adenosine—ADK—Metabolism—AQP1—nephrolithiasis	0.0015	0.00275	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00148	0.00271	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00146	0.00268	CbGpPWpGaD
Adenosine—ADA—Metabolism—APRT—nephrolithiasis	0.00143	0.00263	CbGpPWpGaD
Adenosine—ADA—Metabolism—SLC26A1—nephrolithiasis	0.00143	0.00263	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RGS14—nephrolithiasis	0.00138	0.00254	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADCY10—nephrolithiasis	0.00138	0.00254	CbGpPWpGaD
Adenosine—ADK—Metabolism—CHRM3—nephrolithiasis	0.00136	0.00249	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—DGKH—nephrolithiasis	0.00135	0.00247	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—PTH—nephrolithiasis	0.00134	0.00245	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00126	0.00231	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RGS14—nephrolithiasis	0.00118	0.00216	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PTH—nephrolithiasis	0.00115	0.00211	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.00114	0.0021	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00114	0.0021	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00107	0.00196	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00107	0.00196	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PTH—nephrolithiasis	0.00105	0.00192	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.00104	0.0019	CbGpPWpGaD
Adenosine—ADA—Metabolism—AQP1—nephrolithiasis	0.00102	0.00187	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PTH—nephrolithiasis	0.00098	0.0018	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000973	0.00178	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—DGKH—nephrolithiasis	0.000935	0.00171	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000935	0.00171	CbGpPWpGaD
Adenosine—ADA—Metabolism—CHRM3—nephrolithiasis	0.000924	0.00169	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RGS14—nephrolithiasis	0.000908	0.00166	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PTH—nephrolithiasis	0.00089	0.00163	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000827	0.00152	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—DGKH—nephrolithiasis	0.000795	0.00146	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000795	0.00146	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000756	0.00139	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000751	0.00138	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000687	0.00126	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000676	0.00124	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTH—nephrolithiasis	0.000618	0.00113	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000614	0.00112	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000614	0.00112	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CHRM3—nephrolithiasis	0.000575	0.00105	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTH—nephrolithiasis	0.000525	0.000963	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000444	0.000813	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTH—nephrolithiasis	0.000406	0.000744	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SPP1—nephrolithiasis	0.00031	0.000569	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SPP1—nephrolithiasis	0.000264	0.000483	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SPP1—nephrolithiasis	0.000204	0.000373	CbGpPWpGaD
